MicroRNA expression differentiates between primary lung tumors and metastases to the lung

Pathology Research and Practice

Volumn 206, Issue 8, 2010, Pages 578-584

  Barshack, Iris ^a,b   Lithwick Yanai, Gila ^c   Afek, Arnon ^a,b   Rosenblatt, Kinneret ^a,b   Tabibian Keissar, Hila ^a   Zepeniuk, Merav ^c   Cohen, Lahav ^c   Dan, Harel ^c   Zion, Orit ^c   Strenov, Yulia ^d   Polak Charcon, Sylvie ^a,b   Perelman, Marina ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c ROSETTA GENOMICS LTD   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

Hsa miR 126; Hsa miR 182; Lung cancer; MicroRNA

Indexed keywords

MICRORNA; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; LUNG METASTASIS; LUNG TUMOR; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; GENETICS; HUMAN; PATHOLOGY; SECONDARY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 77954316346     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.03.005     Document Type: Article

References (66)

1. Abrams H.L., Spiro R., Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950, 3:74-85.
2. Crow J., Slavin G., Kreel L. Pulmonary metastasis: a pathologic and radiologic study. Cancer 1981, 47:2595-2602.
3. Farell J. Pulmonary metastasis: a pathologic, clinical, roentgenologic study based on 78 cases seen at necropsy. Radiology 1935, 24:444-451.
4. Johnson R.M., Lindskog G.E. 100 cases of tumor metastatic to lung and mediastinum. Treatment and results. JAMA 1967, 202:94-98.
5. Zetter B.R. The cellular basis of site-specific tumor metastasis. N. Engl. J. Med. 1990, 322:605-612.
6. Bejarano P.A., Baughman R.P., Biddinger P.W., Miller M.A., Fenoglio-Preiser C., al-Kafaji B., Di Lauro R., Whitsett J.A. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod. Pathol. 1996, 9:445-452.
7. Bejarano P.A., Mousavi F. Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity. Arch. Pathol. Lab. Med. 2003, 127:193-195.
8. Chhieng D.C., Cangiarella J.F., Zakowski M.F., Goswami S., Cohen J.M., Yee H.T. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer 2001, 93:330-336.
9. Struski S., Doco-Fenzy M., Cornillet-Lefebvre P. Compilation of published comparative genomic hybridization studies. Cancer Genet. Cytogenet. 2002, 135:63-90.
10. Cagle P.T., Taylor L.D., Schwartz M.R., Ramzy I., Elder F.F. Cytogenetic abnormalities common to adenocarcinoma metastatic to the pleura. Cancer Genet. Cytogenet. 1989, 39:219-225.
11. Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., Baehner F.L., Walker M.G., Watson D., Park T., Hiller W., Fisher E.R., Wickerham D.L., Bryant J., Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 2004, 351:2817-2826.
12. Paik S., Tang G., Shak S., Kim C., Baker J., Kim W., Cronin M., Baehner F.L., Watson D., Bryant J., Costantino J.P., Geyer C.E., et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J. Clin. Oncol. 2006, 24:3726-3734.
13. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., Parrish M., Atsma D., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002, 347:1999-2009.
14. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., Lin L., Chen G., Gharib T.G., Thomas D.G., Lizyness M.L., Kuick R., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 2002, 8:816-824.
15. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., Loda M., Weber G., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13790-13795.
16. Potti A., Mukherjee S., Petersen R., Dressman H.K., Bild A., Koontz J., Kratzke R., Watson M.A., Kelley M., Ginsburg G.S., West M., Harpole D.H., Nevins J.R. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N. Engl. J. Med. 2006, 355:570-580.
17. Hummel M., Bentink S., Berger H., Klapper W., Wessendorf S., Barth T.F., Bernd H.W., Cogliatti S.B., Dierlamm J., Feller A.C., Hansmann M.L., Haralambieva E., et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 2006, 354:2419-2430.
18. Morgensztern D., Martin M.G., Lossos I.S. Gene expression profiling in diffuse large B-cell lymphoma. Leuk. Lymphoma 2007, 48:669-682.
19. Ramaswamy S., Tamayo P., Rifkin R., Mukherjee S., Yeang C.H., Angelo M., Ladd C., Reich M., Latulippe E., Mesirov J.P., Poggio T., Gerald W., et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15149-15154.
20. Ma X.J., Patel R., Wang X., Salunga R., Murage J., Desai R., Tuggle J.T., Wang W., Chu S., Stecker K., Raja R., Robin H., et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch. Pathol. Lab. Med. 2006, 130:465-473.
21. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
22. Rosenfeld N., Aharonov R., Meiri E., Rosenwald S., Spector Y., Zepeniuk M., Benjamin H., Shabes N., Tabak S., Levy A., Lebanony D., Goren Y., et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol. 2008, 26:462-469.
23. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2257-2261.
24. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
25. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
26. Rajewsky N. microRNA target predictions in animals. Nat. Genet. 2006, 38(Suppl.):S8-S13.
27. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 2005, 37:766-770.
28. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Menard S., Palazzo J.P., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
29. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., Fedele V., Ginzinger D., Getts R., Haqq C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 2006, 5:24.
30. Michael M.Z., O'Connor S.M., van Holst Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 2003, 1:882-891.
31. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., Calin G.A., Liu C.G., Croce C.M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
32. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., Calin G.A., Liu C.G., Franssila K., Suster S., Kloos R.T., Croce C.M., de la Chapelle A. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:19075-19080.
33. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., Morgan D.L., Postier R.G., Brackett D.J., Schmittgen T.D. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 2007, 120:1046-1054.
34. Welch C., Chen Y., Stallings R.L. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007, 26:5017-5022.
35. Anderson P. A place for RNAi. Dev. Cell 2005, 9:311-312.
36. Hornstein E., Mansfield J.H., Yekta S., Hu J.K., Harfe B.D., McManus M.T., Baskerville S., Bartel D.P., Tabin C.J. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 2005, 438:671-674.
37. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
38. Gaur A., Jewell D.A., Liang Y., Ridzon D., Moore J.H., Chen C., Ambros V.R., Israel M.A. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007, 67:2456-2468.
39. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 2007, 26:731-743.
40. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006, 34:D140-D144.
41. Thomson J.M., Parker J., Perou C.M., Hammond S.M. A custom microarray platform for analysis of microRNA gene expression. Nat. Methods 2004, 1:47-53.
42. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushnir M., Cholakh H., Melamed N., Bentwich Z., Hod M., et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008, 3:e3148.
43. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
44. Nass D., Rosenwald S., Meiri E., Gilad S., Tabibian-Keissar H., Schlosberg A., Kuker H., Sion-Vardy N., Tobar A., Kharenko O., Sitbon E., Yanai G., et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 2009, 19:375-383.
45. Lebanony D., Benjamin H., Gilad S., Ezagouri M., Dov A., Ashkenazi K., Gefen N., Izraeli S., Rechavi G., Pass H., Nonaka D., Li J., et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from non-squamous non-small-cell lung carcinoma. J. Clin. Oncol. 2009, 27:2030-2037.
46. Travis W.D., Garg K., Franklin W.A., Wistuba I.I., Sabloff B., Noguchi M., Kakinuma R., Zakowski M., Ginsberg M., Padera R., Jacobson F., Johnson B.E., et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J. Thorac. Oncol. 2006, 1:S13-S19.
47. Li H.C., Schmidt L., Greenson J.K., Chang A.C., Myers J.L. Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature. Am. J. Clin. Pathol. 2009, 131:129-133.
48. Ritter J.H., Boucher L.D., Wick M.R. Peripheral pulmonary adenocarcinomas with bronchioloalveolar features: immunophenotypes correlate with histologic patterns. Mod. Pathol. 1998, 11:566-572.
49. Beuvink I., Kolb F.A., Budach W., Garnier A., Lange J., Natt F., Dengler U., Hall J., Filipowicz W., Weiler J. A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Res. 2007, 35:e52.
50. Harris T.A., Yamakuchi M., Ferlito M., Mendell J.T., Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1516-1521.
51. Shingara J., Keiger K., Shelton J., Laosinchai-Wolf W., Powers P., Conrad R., Brown D., Labourier E. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005, 11:1461-1470.
52. Wienholds E., Kloosterman W.P., Miska E., Alvarez-Saavedra E., Berezikov E., de Bruijn E., Horvitz H.R., Kauppinen S., Plasterk R.H. MicroRNA expression in zebrafish embryonic development. Science 2005, 309:310-311.
53. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., Wythe J.D., Ivey K.N., Bruneau B.G., Stainier D.Y., Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 2008, 15:272-284.
54. Wang S., Aurora A.B., Johnson B.A., Qi X., McAnally J., Hill J.A., Richardson J.A., Bassel-Duby R., Olson E.N. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 2008, 15:261-271.
55. Guo C., Sah J.F., Beard L., Willson J.K., Markowitz S.D., Guda K. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008, 47:939-946.
56. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
57. Kalscheuer S., Zhang X., Zeng Y., Upadhyaya P. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 2008, 29:2394-2399.
58. Crawford M., Brawner E., Batte K., Yu L., Hunter M.G., Otterson G.A., Nuovo G., Marsh C.B., Nana-Sinkam S.P. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 2008, 373:607-612.
59. Segura M.F., Hanniford D., Menendez S., Reavie L., Zou X., Alvarez-Diaz S., Zakrzewski J., Blochin E., Rose A., Bogunovic D., Polsky D., Wei J., et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(6):1814-1819.
60. Pierce M.L., Weston M.D., Fritzsch B., Gabel H.W., Ruvkun G., Soukup G.A. MicroRNA-183 family conservation and ciliated neurosensory organ expression. Evol. Dev. 2008, 10:106-113.
61. Ryan D.G., Oliveira-Fernandes M., Lavker R.M. MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol. Vis. 2006, 12:1175-1184.
62. Wang G., Mao W., Zheng S. MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett. 2008, 582:3663-3668.
63. Bracken C.P., Gregory P.A., Kolesnikoff N., Bert A.G., Wang J., Shannon M.F., Goodall G.J. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68:7846-7854.
64. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
65. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283:14910-14914.
66. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.